Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths

[1]  Siu Hing Lo,et al.  Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme , 2014, Gut.

[2]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[3]  Atle Fretheim,et al.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. , 2013, The Cochrane database of systematic reviews.

[4]  J. Cairns,et al.  Review of economic evidence in the prevention and early detection of colorectal cancer , 2013, Health Economics Review.

[5]  S. Duffy,et al.  Screening and Primary prevention of Colorectal Cancer: a Review of sex-specific and site-specific differences , 2013, Journal of medical screening.

[6]  H. Brenner,et al.  Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. , 2013, European journal of cancer.

[7]  Á. Lanas,et al.  Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. , 2013, Journal of the National Cancer Institute.

[8]  S. Whyte,et al.  Reappraisal of the options for colorectal cancer screening in England , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[9]  P. Quirke,et al.  A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme , 2012, British Journal of Cancer.

[10]  E. Kuipers,et al.  Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme , 2012, International journal of cancer.

[11]  C M Mangham,et al.  Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up , 2011, Gut.

[12]  S. Moss,et al.  Edinburgh Research Explorer Performance measures in three rounds of the English bowel cancer screening pilot , 2022 .

[13]  J. Habbema,et al.  Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. , 2010, European journal of cancer.

[14]  J. Wardle,et al.  Flexible Sigmoidoscopy Screening for Colorectal Cancer: Uptake in a Population-based Pilot Programme , 2010, Journal of medical screening.

[15]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[16]  C. von Wagner,et al.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests , 2010, Gut.

[17]  D. Parkin,et al.  Predicting the impact of the screening programme for colorectal cancer in the UK , 2008, Journal of medical screening.

[18]  S. Moss,et al.  Population screening for colorectal cancer: the implications of an ageing population , 2008, British Journal of Cancer.

[19]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[20]  H. Brenner,et al.  Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies , 2007, Gut.

[21]  P. Bossuyt,et al.  Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.

[22]  Justin C.Y. Wu,et al.  Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. , 2003, Gastroenterology.

[23]  E. Wilkinson.  Cancer Research UK , 2002 .

[24]  R. Taylor,et al.  NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE) , 2002, International Journal of Technology Assessment in Health Care.

[25]  J. Cuzick,et al.  Prevention of colorectal cancer by once-only sigmoidoscopy , 1993, The Lancet.